Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

Identification of Mycobacterium tuberculosis Infection in Infants and Children With Partial Discrimination Between Active Disease and Asymptomatic Infection.

Dreesman A, Dirix V, Smits K, Corbière V, Van Praet A, Debulpaep S, De Schutter I, Felderhof MK, Malfroot A, Singh M, Locht C, Mouchet F, Mascart F.

Front Pediatr. 2019 Jul 25;7:311. doi: 10.3389/fped.2019.00311. eCollection 2019.

2.

Respiratory Bacterial Culture Sampling in Expectorating and Non-expectorating Patients With Cystic Fibrosis.

Eyns H, Piérard D, De Wachter E, Eeckhout L, Vaes P, Malfroot A.

Front Pediatr. 2018 Dec 18;6:403. doi: 10.3389/fped.2018.00403. eCollection 2018.

3.

Emergence of livestock-associated MRSA isolated from cystic fibrosis patients: Result of a Belgian national survey.

Dodémont M, Argudín MA, Willekens J, Vanderhelst E, Pierard D, Miendje Deyi VY, Hanssens L, Franckx H, Schelstraete P, Leroux-Roels I, Nonhoff C, Deplano A, Knoop C, Malfroot A, Denis O.

J Cyst Fibros. 2019 Jan;18(1):86-93. doi: 10.1016/j.jcf.2018.04.008. Epub 2018 May 24.

PMID:
29805051
4.

Intrapulmonary percussive ventilation improves lung function in cystic fibrosis patients chronically colonized with Pseudomonas aeruginosa: a pilot cross-over study.

Dingemans J, Eyns H, Willekens J, Monsieurs P, Van Houdt R, Cornelis P, Malfroot A, Crabbé A.

Eur J Clin Microbiol Infect Dis. 2018 Jun;37(6):1143-1151. doi: 10.1007/s10096-018-3232-8. Epub 2018 Mar 20.

PMID:
29560543
5.

Acute Pain Perception During Different Sampling Methods for Respiratory Culture in Cystic Fibrosis Patients.

Eyns H, De Wachter E, Malfroot A, Vaes P.

J Pain Symptom Manage. 2018 Mar;55(3):872-880. doi: 10.1016/j.jpainsymman.2017.11.004. Epub 2017 Nov 14.

PMID:
29154891
6.

Age-Stratified T Cell Responses in Children Infected with Mycobacterium tuberculosis.

Dreesman A, Corbière V, Dirix V, Smits K, Debulpaep S, De Schutter I, Libin M, Singh M, Malfroot A, Locht C, Mascart F.

Front Immunol. 2017 Sep 5;8:1059. doi: 10.3389/fimmu.2017.01059. eCollection 2017.

7.

What can the CF registry tell us about rare CFTR-mutations? A Belgian study.

De Wachter E, Thomas M, Wanyama SS, Seneca S, Malfroot A.

Orphanet J Rare Dis. 2017 Aug 22;12(1):142. doi: 10.1186/s13023-017-0694-1.

8.

Inhaled dry powder mannitol in children with cystic fibrosis: A randomised efficacy and safety trial.

De Boeck K, Haarman E, Hull J, Lands LC, Moeller A, Munck A, Riethmüller J, Tiddens H, Volpi S, Leadbetter J, Charlton B, Malfroot A; DPM-CF-204 Study Group.

J Cyst Fibros. 2017 May;16(3):380-387. doi: 10.1016/j.jcf.2017.02.003. Epub 2017 Mar 1.

9.

Effect of Shear Stress on Pseudomonas aeruginosa Isolated from the Cystic Fibrosis Lung.

Dingemans J, Monsieurs P, Yu SH, Crabbé A, Förstner KU, Malfroot A, Cornelis P, Van Houdt R.

MBio. 2016 Aug 2;7(4). pii: e00813-16. doi: 10.1128/mBio.00813-16.

10.

Corrigendum: The ciliopathy-associated CPLANE proteins direct basal body recruitment of intraflagellar transport machinery.

Toriyama M, Lee C, Taylor SP, Duran I, Cohn DH, Bruel AL, Tabler JM, Drew K, Kelly MR, Kim S, Park TJ, Braun DA, Pierquin G, Biver A, Wagner K, Malfroot A, Panigrahi I, Franco B, Al-Lami HA, Yeung Y, Choi YJ; University of Washington Center for Mendelian Genomics, Duffourd Y, Faivre L, Rivière JB, Chen J, Liu KJ, Marcotte EM, Hildebrandt F, Thauvin-Robinet C, Krakow D, Jackson PK, Wallingford JB.

Nat Genet. 2016 Jul 27;48(8):970. doi: 10.1038/ng0816-970b. No abstract available.

PMID:
27463398
11.

The ciliopathy-associated CPLANE proteins direct basal body recruitment of intraflagellar transport machinery.

Toriyama M, Lee C, Taylor SP, Duran I, Cohn DH, Bruel AL, Tabler JM, Drew K, Kelly MR, Kim S, Park TJ, Braun DA, Pierquin G, Biver A, Wagner K, Malfroot A, Panigrahi I, Franco B, Al-Lami HA, Yeung Y, Choi YJ; University of Washington Center for Mendelian Genomics, Duffourd Y, Faivre L, Rivière JB, Chen J, Liu KJ, Marcotte EM, Hildebrandt F, Thauvin-Robinet C, Krakow D, Jackson PK, Wallingford JB.

Nat Genet. 2016 Jun;48(6):648-56. doi: 10.1038/ng.3558. Epub 2016 May 9. Erratum in: Nat Genet. 2016 Jul 27;48(8):970.

12.

The clinical benefits of long-term supplementation with omega-3 fatty acids in cystic fibrosis patients - A pilot study.

Hanssens L, Thiébaut I, Lefèvre N, Malfroot A, Knoop C, Duchateau J, Casimir G.

Prostaglandins Leukot Essent Fatty Acids. 2016 May;108:45-50. doi: 10.1016/j.plefa.2016.03.014. Epub 2016 Mar 28.

PMID:
27154364
13.

Gastric emptying and gastro-oesophageal reflux in children with cystic fibrosis.

Hauser B, De Schepper J, Malfroot A, De Wachter E, De Schutter I, Keymolen K, Vandenplas Y.

J Cyst Fibros. 2016 Jul;15(4):540-7. doi: 10.1016/j.jcf.2015.12.015. Epub 2016 Jan 8.

14.

A semi-blinded study comparing 2 methods of measuring nasal potential difference: Subcutaneous needle versus dermal abrasion.

De Wachter E, De Schutter I, Meulemans A, Buyl R, Malfroot A.

J Cyst Fibros. 2016 Jan;15(1):60-6. doi: 10.1016/j.jcf.2015.06.007. Epub 2015 Jul 16.

15.

Immunodeficiency in a Child with Rapadilino Syndrome: A Case Report and Review of the Literature.

Vollebregt MM, Malfroot A, De Raedemaecker M, van der Burg M, van der Werff Ten Bosch JE.

Case Reports Immunol. 2015;2015:137368. doi: 10.1155/2015/137368. Epub 2015 May 6.

16.

Investigation of Saliva as an Alternative to Plasma Monitoring of Voriconazole.

Vanstraelen K, Maertens J, Augustijns P, Lagrou K, de Loor H, Mols R, Annaert P, Malfroot A, Spriet I.

Clin Pharmacokinet. 2015 Nov;54(11):1151-60. doi: 10.1007/s40262-015-0269-z.

PMID:
25910879
17.

Quantitative bone ultrasound at the distal radius in adults with cystic fibrosis.

Roggen I, Louis O, Van Biervliet S, Van Daele S, Robberecht E, De Wachter E, Malfroot A, De Waele K, Gies I, Vanbesien J, De Schepper J.

Ultrasound Med Biol. 2015 Jan;41(1):334-8. doi: 10.1016/j.ultrasmedbio.2014.08.003. Epub 2014 Oct 22.

PMID:
25438860
18.

Increase in ventilated air spaces after eradication of chronic methicillin-resistant Staphylococcus aureus infection in cystic fibrosis patients.

Vanderhelst E, De Wachter E, Willekens J, Schuermans D, Vincken W, Malfroot A, Verbanck S.

Acta Clin Belg. 2015 Feb;70(1):30-3. doi: 10.1179/2295333714Y.0000000079. Epub 2014 Sep 24.

PMID:
25253536
19.

The Lung Clearance Index as a probe for the effectiveness of short-term therapies in cystic fibrosis lung disease.

Vanderhelst E, De Meirleir L, Schuermans D, Malfroot A, Vincken W, Verbanck S.

J Cyst Fibros. 2015 Mar;14(2):285-6. doi: 10.1016/j.jcf.2014.08.004. Epub 2014 Aug 28. No abstract available.

20.

Pulmonary disease in cystic fibrosis: assessment with chest CT at chest radiography dose levels.

Ernst CW, Basten IA, Ilsen B, Buls N, Van Gompel G, De Wachter E, Nieboer KH, Verhelle F, Malfroot A, Coomans D, De Maeseneer M, de Mey J.

Radiology. 2014 Nov;273(2):597-605. doi: 10.1148/radiol.14132201. Epub 2014 Jul 25.

PMID:
25057981
21.

Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial.

Kerem E, Konstan MW, De Boeck K, Accurso FJ, Sermet-Gaudelus I, Wilschanski M, Elborn JS, Melotti P, Bronsveld I, Fajac I, Malfroot A, Rosenbluth DB, Walker PA, McColley SA, Knoop C, Quattrucci S, Rietschel E, Zeitlin PL, Barth J, Elfring GL, Welch EM, Branstrom A, Spiegel RJ, Peltz SW, Ajayi T, Rowe SM; Cystic Fibrosis Ataluren Study Group.

Lancet Respir Med. 2014 Jul;2(7):539-47. doi: 10.1016/S2213-2600(14)70100-6. Epub 2014 May 15.

22.

Evidence of an acinar response following treatment for exacerbation in adult patients with cystic fibrosis.

Vanderhelst E, De Meirleir L, Schuermans D, Malfroot A, Vincken W, Verbanck S.

Respiration. 2014;87(6):492-8. doi: 10.1159/000360772. Epub 2014 May 8.

23.

Nutritional status of children hospitalized for parapneumonic effusion.

Huysentruyt K, Alliet P, Raes M, Willekens J, De Schutter I, De Wachter E, Malfroot A, Devreker T, Goyens P, Vandenplas Y, De Schepper J.

PLoS One. 2014 Apr 4;9(4):e94242. doi: 10.1371/journal.pone.0094242. eCollection 2014.

24.

The deletion of TonB-dependent receptor genes is part of the genome reduction process that occurs during adaptation of Pseudomonas aeruginosa to the cystic fibrosis lung.

Dingemans J, Ye L, Hildebrand F, Tontodonati F, Craggs M, Bilocq F, De Vos D, Crabbé A, Van Houdt R, Malfroot A, Cornelis P.

Pathog Dis. 2014 Jun;71(1):26-38. doi: 10.1111/2049-632X.12170. Epub 2014 Apr 16.

PMID:
24659602
25.

Pneumococcal aetiology and serotype distribution in paediatric community-acquired pneumonia.

De Schutter I, Vergison A, Tuerlinckx D, Raes M, Smet J, Smeesters PR, Verhaegen J, Mascart F, Surmont F, Malfroot A.

PLoS One. 2014 Feb 18;9(2):e89013. doi: 10.1371/journal.pone.0089013. eCollection 2014.

26.

How long should we maintain long-term azithromycin treatment in cystic fibrosis patients?

Willekens J, Eyns H, Malfroot A.

Pediatr Pulmonol. 2015 Jan;50(1):103-4. doi: 10.1002/ppul.22981. Epub 2014 Jan 24. No abstract available.

PMID:
24464958
27.

Primary ciliary dyskinesia: critical evaluation of clinical symptoms and diagnosis in patients with normal and abnormal ultrastructure.

Boon M, Smits A, Cuppens H, Jaspers M, Proesmans M, Dupont LJ, Vermeulen FL, Van Daele S, Malfroot A, Godding V, Jorissen M, De Boeck K.

Orphanet J Rare Dis. 2014 Jan 22;9:11. doi: 10.1186/1750-1172-9-11.

28.

Sampling and decontamination method for culture of nontuberculous mycobacteria in respiratory samples of cystic fibrosis patients.

De Bel A, De Geyter D, De Schutter I, Mouton C, Wellemans I, Hanssens L, Schelstraete P, Malfroot A, Pierard D.

J Clin Microbiol. 2013 Dec;51(12):4204-6. doi: 10.1128/JCM.02035-13. Epub 2013 Sep 18.

29.

Ferrous iron is a significant component of bioavailable iron in cystic fibrosis airways.

Hunter RC, Asfour F, Dingemans J, Osuna BL, Samad T, Malfroot A, Cornelis P, Newman DK.

MBio. 2013 Aug 20;4(4). pii: e00557-13. doi: 10.1128/mBio.00557-13.

30.

Eradication of chronic methicillin-resistant Staphylococcus aureus infection in cystic fibrosis patients. An observational prospective cohort study of 11 patients.

Vanderhelst E, De Wachter E, Willekens J, Piérard D, Vincken W, Malfroot A.

J Cyst Fibros. 2013 Dec;12(6):662-6. doi: 10.1016/j.jcf.2013.04.009. Epub 2013 May 21.

31.

Acinar and conductive ventilation heterogeneity in severe CF lung disease: back to the model.

Verbanck S, Paiva M, Schuermans D, Malfroot A, Vincken W, Vanderhelst E.

Respir Physiol Neurobiol. 2013 Aug 15;188(2):124-32. doi: 10.1016/j.resp.2013.05.011. Epub 2013 May 18.

PMID:
23692927
32.

Specific medical and surgical treatment for chronic inflammatory diseases in children.

Boudewyns A, Antunes J, Bernheim N, Claes J, De Dooy J, De Leenheer E, De Roeck K, Hellings P, de Varebeke SJ, Jorissen M, Ketelslagers K, Lemkens N, Lemkens P, Leupe P, Malfroot A, Maris M, Michiels E, Van Crombrugge L, Vandenplas Y, Verhulst S, Eloy P, Watelet JB.

B-ENT. 2012;8 Suppl 19:135-66. Review.

PMID:
23431617
33.

Evaluation of a WHO-validated serotype-specific serological assay for the diagnosis of pneumococcal etiology in children with community-acquired pneumonia.

Tuerlinckx D, Smet J, De Schutter I, Jamart J, Vergison A, Raes M, Smeesters PR, Verhaegen J, Surmont F, Malfroot A, Mascart F.

Pediatr Infect Dis J. 2013 Jul;32(7):e277-84. doi: 10.1097/INF.0b013e31828c363f.

PMID:
23407099
34.

Lung clearance index in adult cystic fibrosis patients: the role of convection-dependent lung units.

Verbanck S, Paiva M, Paeps E, Schuermans D, Malfroot A, Vincken W, Vanderhelst E.

Eur Respir J. 2013 Aug;42(2):380-8. doi: 10.1183/09031936.00125312. Epub 2012 Oct 25.

35.

Reply to 'Methicillin-resistant Staphylococcus aureus'.

Vanderhelst E, De Meirleir L, Verbanck S, Piérard D, Vincken W, Malfroot A.

J Cyst Fibros. 2013 Mar;12(2):183. doi: 10.1016/j.jcf.2012.08.002. Epub 2012 Aug 29. No abstract available.

36.

In young children, persistent wheezing is associated with bronchial bacterial infection: a retrospective analysis.

De Schutter I, Dreesman A, Soetens O, De Waele M, Crokaert F, Verhaegen J, Piérard D, Malfroot A.

BMC Pediatr. 2012 Jun 22;12:83. doi: 10.1186/1471-2431-12-83.

37.

Comparative bone status assessment by dual energy X-ray absorptiometry, peripheral quantitative computed tomography and quantitative ultrasound in adolescents and young adults with cystic fibrosis.

De Schepper J, Roggen I, Van Biervliet S, Robberecht E, Gies I, De Waele K, De Wachter E, Malfroot A, De Baets F, Toye K, Goemaere S, Louis O.

J Cyst Fibros. 2012 Mar;11(2):119-24. doi: 10.1016/j.jcf.2011.10.004. Epub 2011 Nov 26.

38.

Pandemic A/H1N1v influenza 2009 in hospitalized children: a multicenter Belgian survey.

Blumental S, Huisman E, Cornet MC, Ferreiro C, De Schutter I, Reynders M, Wybo I, Kabamba-Mukadi B, Armano R, Hermans D, Nassogne MC, Mahadeb B, Fonteyne C, Van Berlaer G, Levy J, Moulin D, Vergison A, Malfroot A, Lepage P.

BMC Infect Dis. 2011 Nov 7;11:313. doi: 10.1186/1471-2334-11-313.

39.

Prevalence and impact on FEV(1) decline of chronic methicillin-resistant Staphylococcus aureus (MRSA) colonization in patients with cystic fibrosis. A single-center, case control study of 165 patients.

Vanderhelst E, De Meirleir L, Verbanck S, Piérard D, Vincken W, Malfroot A.

J Cyst Fibros. 2012 Jan;11(1):2-7. doi: 10.1016/j.jcf.2011.08.006. Epub 2011 Sep 9.

40.

Malacia, inflammation and bronchoalveolar lavage culture in children with persistent respiratory symptoms.

De Baets F, De Schutter I, Aarts C, Haerynck F, Van Daele S, De Wachter E, Malfroot A, Schelstraete P.

Eur Respir J. 2012 Feb;39(2):392-5. doi: 10.1183/09031936.00035111. Epub 2011 Jul 20.

41.

Treatment of infants and toddlers with cystic fibrosis-related pancreatic insufficiency and fat malabsorption with pancrelipase MT.

Van de Vijver E, Desager K, Mulberg AE, Staelens S, Verkade HJ, Bodewes FA, Malfroot A, Hauser B, Sinaasappel M, Van Biervliet S, Behm M, Pelckmans P, Callens D, Veereman-Wauters G.

J Pediatr Gastroenterol Nutr. 2011 Jul;53(1):61-4. doi: 10.1097/MPG.0b013e31820e208e.

PMID:
21694537
42.

Microbiology of bronchoalveolar lavage fluid in children with acute nonresponding or recurrent community-acquired pneumonia: identification of nontypeable Haemophilus influenzae as a major pathogen.

De Schutter I, De Wachter E, Crokaert F, Verhaegen J, Soetens O, Piérard D, Malfroot A.

Clin Infect Dis. 2011 Jun 15;52(12):1437-44. doi: 10.1093/cid/cir235.

PMID:
21628484
43.

Immunogenicity and safety of a measles-mumps-rubella-varicella vaccine following a 4-week or a 12-month interval between two doses.

Rümke HC, Loch HP, Hoppenbrouwers K, Vandermeulen C, Malfroot A, Helm K, Douha M, Willems P.

Vaccine. 2011 May 17;29(22):3842-9. doi: 10.1016/j.vaccine.2011.02.067. Epub 2011 Mar 5. Review.

PMID:
21382484
44.

Impact of conjugate 7-valent vaccination in Belgium: addressing methodological challenges.

Hanquet G, Lernout T, Vergison A, Verhaegen J, Kissling E, Tuerlinckx D, Malfroot A, Swennen B, Sabbe M; Belgian IPD Scientific Committee.

Vaccine. 2011 Apr 5;29(16):2856-64. doi: 10.1016/j.vaccine.2011.02.016. Epub 2011 Feb 19.

PMID:
21342667
45.

Siblings of children with cystic fibrosis: quality of life and the impact of illness.

Havermans T, Wuytack L, Deboel J, Tijtgat A, Malfroot A, De Boeck C, Proesmans M.

Child Care Health Dev. 2011 Mar;37(2):252-60. doi: 10.1111/j.1365-2214.2010.01165.x. Epub 2010 Nov 18.

PMID:
21083689
46.

The relationship between gastroesophageal reflux and cough in children with chronic unexplained cough using combined impedance-pH-manometry recordings.

Blondeau K, Mertens V, Dupont L, Pauwels A, Farré R, Malfroot A, De Wachter E, De Schutter I, Hauser B, Vandenplas Y, Sifrim D.

Pediatr Pulmonol. 2011 Mar;46(3):286-94. doi: 10.1002/ppul.21365. Epub 2010 Oct 22.

PMID:
20967945
47.

Comparison of culture and qPCR for the detection of Pseudomonas aeruginosa in not chronically infected cystic fibrosis patients.

Deschaght P, Schelstraete P, Lopes dos Santos Santiago G, Van Simaey L, Haerynck F, Van Daele S, De Wachter E, Malfroot A, Lebecque P, Knoop C, Casimir G, Boboli H, Pierart F, Desager K, Vaneechoutte M, De Baets F.

BMC Microbiol. 2010 Sep 24;10:245. doi: 10.1186/1471-2180-10-245.

48.

Travelling with cystic fibrosis: recommendations for patients and care team members.

Hirche TO, Bradley J, d'Alquen D, De Boeck K, Dembski B, Elborn JS, Gleiber W, Lais C, Malfroot A, Wagner TO; European Centres of Reference Network for Cystic Fibrosis (ECORN-CF) Study Group.

J Cyst Fibros. 2010 Dec;9(6):385-99. doi: 10.1016/j.jcf.2010.08.013. Epub 2010 Sep 17. Review.

49.

Safety of MF59-adjuvanted versus non-adjuvanted influenza vaccines in children and adolescents: an integrated analysis.

Black S, Della Cioppa G, Malfroot A, Nacci P, Nicolay U, Pellegrini M, Sokal E, Vertruyen A.

Vaccine. 2010 Oct 21;28(45):7331-6. doi: 10.1016/j.vaccine.2010.08.075. Epub 2010 Sep 15.

PMID:
20813217
50.

Milk protein and Oil-Red-O staining of alveolar macrophages in chronic respiratory disease of infancy.

De Baets F, Aarts C, Van Daele S, Haerynck F, De Wachter E, De Schutter I, Malfroot A, Schelstraete P.

Pediatr Pulmonol. 2010 Dec;45(12):1213-9. doi: 10.1002/ppul.21310. Epub 2010 Aug 17.

PMID:
20717909

Supplemental Content

Loading ...
Support Center